These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 441437

  • 21. HCG, progesterone and 17-beta-estradiol levels during extra-amniotically induced early abortion by a new prostaglandin derivative (Sulprostone).
    Nilsson S, Zador G, Nygren KG, Wide L.
    Gynecol Obstet Invest; 1981; 12(4):203-10. PubMed ID: 7250783
    [Abstract] [Full Text] [Related]

  • 22. Pregnancy interception with a combination of prostaglandins: studies in monkeys.
    Wilks JW.
    Science; 1983 Sep 30; 221(4618):1407-9. PubMed ID: 6612350
    [Abstract] [Full Text] [Related]

  • 23. The role of a long-acting vaginal suppository of 15-ME-PGF2 alpha in first and second trimester abortion.
    Lauersen NH, Wilson KH.
    Adv Prostaglandin Thromboxane Res; 1980 Sep 30; 8():1435-41. PubMed ID: 7376994
    [No Abstract] [Full Text] [Related]

  • 24. Interruption of early first trimester pregnancy by single vaginal administration of 15-methyl-pgf2 alpha-methyl ester.
    Gréen K, Bygdeman M, Bremme K.
    Contraception; 1978 Dec 30; 18(6):551-60. PubMed ID: 750185
    [No Abstract] [Full Text] [Related]

  • 25. Suppression of concentration of endometrial prostaglandin in early intra-uterine and ectopic pregnancy in women.
    Abel MH, Smith SK, Baird DT.
    J Endocrinol; 1980 Jun 30; 85(3):379-86. PubMed ID: 7411005
    [Abstract] [Full Text] [Related]

  • 26. Induction of abortion by vaginal administration of 15(s)15-methyl prostaglandin F2alpha methyl ester. A comparison of two delivery systems.
    Bygdeman M, Gréen K, Lundström V, Ramadan M, Fotiou S, Bergström S.
    Prostaglandins; 1976 Jun 30; 12 Suppl():27-51. PubMed ID: 968064
    [Abstract] [Full Text] [Related]

  • 27. Hormonal changes in patients undergoing therapeutic abortion with prostaglandin F2alpha, 15(S)-15-methyl-prostaglandin F2alpha and hypertonic saline.
    Laumas KR, Rahman SA, Hingorani V, Puri CP, Baliga N, Laumas V.
    Contraception; 1974 Dec 30; 10(6):617-36. PubMed ID: 4448072
    [No Abstract] [Full Text] [Related]

  • 28. Suppression of uterine activity and abortion by inhibition of prostaglandin synthesis.
    Csapo AI, Henzl MR, Kaihola HL, Kivikoski A, Pulkkinen MO.
    Prostaglandins; 1974 Jul 10; 7(1):39-47. PubMed ID: 4605187
    [Abstract] [Full Text] [Related]

  • 29. [Effect of 15-methyl-prostaglandin F2 alpha used for dilating the cervix uteri before abortion on endogenous prostaglandin F2 alpha synthesis].
    Goncharova VN, Morozova MS, Razina LG, Manuilova IA, Murashko LE.
    Akush Ginekol (Mosk); 1981 Dec 10; (12):37-8. PubMed ID: 6950671
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Clinical and hormonal studies with 3 mg 15 (S) 15-methyl-PGF2alpha methyl ester long-acting single vaginal suppository.
    Jagannatha KT, Puri CP, Kinra G, Agarwal N, Jain AK, Rahman SA, Laumas KR, Hingorani V.
    Contraception; 1978 Mar 10; 17(3):267-82. PubMed ID: 648150
    [No Abstract] [Full Text] [Related]

  • 32. Evaluation of a single dose schedule of 15 (S) 15 methyl PGF2 alpha methyl ester suppository for the termination of 10-14 weeks of pregnancy.
    Kinra G, Agarwal N, Jagannath KT, Hingorani V.
    Contraception; 1978 May 10; 17(5):455-64. PubMed ID: 657810
    [No Abstract] [Full Text] [Related]

  • 33. Plasma levels of 15 (S) 15-methyl-PGF 2 alpha-methyl ester following vaginal administration for induction of abortion in women.
    Bhaskar A, Dimov V, Baliga S, Kinra G, Hingorani V, Laumas KR.
    Contraception; 1979 Nov 10; 20(5):519-31. PubMed ID: 527343
    [Abstract] [Full Text] [Related]

  • 34. The current status of prostaglandins as abortifacients.
    Brenner WE.
    Am J Obstet Gynecol; 1975 Oct 01; 123(3):306-28. PubMed ID: 810025
    [Abstract] [Full Text] [Related]

  • 35. Outpatient postconceptional fertility control with vaginally administered 15(S) 15-methyl-PGF2alpha-methyl ester.
    Bygdeman M, Martin JN, Eneroth P, Leader A, Lundström V.
    Am J Obstet Gynecol; 1976 Mar 01; 124(5):495-8. PubMed ID: 1258906
    [Abstract] [Full Text] [Related]

  • 36. Termination of early gestation with intramuscular (15S)-15 methyl prostaglandin F2 alpha.
    Brenner PF, Lumkin ME, Ballard C, Mishell DR.
    Contraception; 1975 Mar 01; 11(3):279-87. PubMed ID: 1116367
    [No Abstract] [Full Text] [Related]

  • 37. Treatment with a single vaginal suppository containing 15-methyl PGF2 alpha methyl ester at expected time of menstruation.
    Kinoshita K, Eneroth P, Bygdeman M.
    Prostaglandins; 1979 Mar 01; 17(3):469-81. PubMed ID: 472340
    [Abstract] [Full Text] [Related]

  • 38. Comparison of two prostaglandins used to terminate midtrimester pregnancy.
    Gookin KS, White CK, Whitworth NS, Wiser WL, Morrison JC.
    South Med J; 1984 Jun 01; 77(6):717-8, 721. PubMed ID: 6587588
    [Abstract] [Full Text] [Related]

  • 39. [Development of a long-acting vaginal suppository for termination of 2d trimester pregnancy and for preoperative cervical dilatation].
    Bygdeman M, Gréen K, Lundström V.
    Lakartidningen; 1977 Nov 16; 74(46):4107-9. PubMed ID: 926943
    [No Abstract] [Full Text] [Related]

  • 40. Cervical dilation with prostaglandin F2 alpha for first trimester abortion.
    Natrajan PK, Tzingounis VA.
    South Med J; 1986 Jul 16; 79(7):830-1. PubMed ID: 3460179
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.